| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate |
2010-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102471331-B |
| titleOfInvention |
The solid orally ingestible of apoptosis protein inhibitor and crystalline form |
| abstract |
The crystalline form of present disclosure relates to (S)-N-((S)-1-cyclohexyl-2-{ (S)-2-[4-(the fluoro-benzoyl of 4-)-thiazol-2-yl]-pyrrolidin-1-yl }-2-oxo-ethyl)-2-methylamino-propionamide, its salt and hydrate.The disclosure content also relates to the solid orally ingestible of (S)-N-((S)-1-cyclohexyl-2-{ (S)-2-[4-(the fluoro-benzoyl of 4-)-thiazol-2-yl]-pyrrolidin-1-yl }-2-oxo-ethyl)-2-methylamino-propionamide, its pharmacologically acceptable salt, solvate (comprising hydrate), and uses their methods for the treatment of. |
| priorityDate |
2009-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |